It highlights the cascade initiated by the binding of antiphospholipid antibodies (aPLs) to anionic phospholipids, the subsequent release of extracellular vesicles, and the activation of Toll-like receptors (TLR7 and TLR9), leading to neuroinflammation and migraine development. The gene discussed is TLR9; the disease is migraine disorder.